Market Research Logo

Emergent BioSolutions Inc (EBS) - Financial and Strategic SWOT Analysis Review

Emergent BioSolutions Inc (EBS) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Emergent BioSolutions Inc (Emergent) is a life sciences company. It focuses on protecting and enhancing life by providing specialized products to governments and healthcare providers. The company develops specialty products targeting public health threats and emerging infectious diseases. Its product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer. Its marketed products include BioThrax (anthrax vaccine adsorbed); WinRho SDF (Rho(D) immune globulin intravenous; (RSDL) reactive skin decontamination lotion; and HepaGam B for the treatment of hepatitis B. Emergent also has a developmental pipeline of candidates targeting dengue and other influenza infections. The company distributes its products in the US and Canada through its commercial sales forces and third party distributors. Emergent is headquartered in Rockville, Maryland, the US.

Emergent BioSolutions Inc Key Recent Developments

Feb 21,2019 Emergent Biosolutions reports fourth quarter and full year 2018 financial results
Feb 12,2019 Emergent BioSolutions names Seamus Mulligan to its Board of Directors
Jan 24,2019 Emergent BioSolutions announces appointment of Robert G. Kramer, Sr. to its board of directors
Jan 07,2019 Emergent BioSolutions announces preliminary 2018 financial results and provides 2019 financial forecast

Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Emergent BioSolutions Inc - Key Facts
Emergent BioSolutions Inc - Key Employees
Emergent BioSolutions Inc - Key Employee Biographies
Emergent BioSolutions Inc - Major Products and Services
Emergent BioSolutions Inc - History
Emergent BioSolutions Inc - Company Statement
Emergent BioSolutions Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Emergent BioSolutions Inc - Business Description
Emergent BioSolutions Inc - Corporate Strategy
Emergent BioSolutions Inc - SWOT Analysis
SWOT Analysis - Overview
Emergent BioSolutions Inc - Strengths
Emergent BioSolutions Inc - Weaknesses
Emergent BioSolutions Inc - Opportunities
Emergent BioSolutions Inc - Threats
Emergent BioSolutions Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Emergent BioSolutions Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 21, 2019: Emergent Biosolutions reports fourth quarter and full year 2018 financial results
Feb 12, 2019: Emergent BioSolutions names Seamus Mulligan to its Board of Directors
Jan 24, 2019: Emergent BioSolutions announces appointment of Robert G. Kramer, Sr. to its board of directors
Jan 07, 2019: Emergent BioSolutions announces preliminary 2018 financial results and provides 2019 financial forecast
Jan 04, 2019: Emergent BioSolutions announces Daniel J. Abdun-Nabi to retire as CEO; Robert G. Kramer, Sr. to become President and CEO
Nov 13, 2018: Emergent BioSolutions Integrates with ABEC to Expand its Manufacturing Capabilities
Nov 01, 2018: Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months of 2018
Oct 24, 2018: Emergent BioSolutions to Offer All Public Libraries and YMCAs in the U.S. Free Opioid Awareness Education and NARCAN (naloxone HCl) Nasal Spray
Sep 24, 2018: Emergent BioSolutions expands manufacturing capability with ABEC dual purpose single-use microbial fermentation / mammalian cell culture systems
Aug 30, 2018: Emergent BioSolutions to acquire Adapt Pharma for up to $735m
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Emergent BioSolutions Inc, Key Facts
Emergent BioSolutions Inc, Key Employees
Emergent BioSolutions Inc, Key Employee Biographies
Emergent BioSolutions Inc, Major Products and Services
Emergent BioSolutions Inc, History
Emergent BioSolutions Inc, Other Locations
Emergent BioSolutions Inc, Subsidiaries
Emergent BioSolutions Inc, Joint Venture
Emergent BioSolutions Inc, Key Competitors
Emergent BioSolutions Inc, Ratios based on current share price
Emergent BioSolutions Inc, Annual Ratios
Emergent BioSolutions Inc, Annual Ratios (Cont...1)
Emergent BioSolutions Inc, Annual Ratios (Cont...2)
Emergent BioSolutions Inc, Interim Ratios
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Emergent BioSolutions Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Emergent BioSolutions Inc, Performance Chart (2014 - 2018)
Emergent BioSolutions Inc, Ratio Charts
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook